Arena Pharmaceuticals is a biopharmaceutical company with a pipeline of internally discovered small molecule product...
MoreArena Pharmaceuticals is a biopharmaceutical company with a pipeline of internally discovered small molecule product candidates identified through its focus on G protein-coupled receptors, or GPCR, drug discovery and technologies. Its goal is to discover, develop and commercialize novel, orally available drugs that address major unmet medical needs by targeting known and novel GPCRs. The company focuses on four therapeutic areas that include metabolic, central nervous system, cardiovascular and inflammatory diseases. Arena has two clinical stage collaborations with major pharmaceutical companies. Merck & Company began a Phase 1 clinical trial of an Arena discovered drug candidate for the treatment of atherosclerosis and related disorders in the third quarter of 2005 while Ortho-McNeil, a Johnson & Johnson company, began a Phase 1 clinical trial of APD668, an Arena discovered drug candidate for the treatment of type 2 diabetes in February 2006. Arena has two other internally discovered, clinical stage drug candidates for major diseases including obesity and insomnia. Arena Pharmaceuticals is located in San Diego, Calif. Less